Fluidigm Company Profile (NASDAQ:FLDM)

About Fluidigm (NASDAQ:FLDM)

Fluidigm logoFluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:FLDM
  • CUSIP: 34385P10
  • Web: www.fluidigm.com
Capitalization:
  • Market Cap: $135.34 million
  • Outstanding Shares: 29,295,000
Average Prices:
  • 50 Day Moving Avg: $5.16
  • 200 Day Moving Avg: $6.11
  • 52 Week Range: $4.31 - $11.05
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.02
  • P/E Growth: 0.27
Sales & Book Value:
  • Annual Revenue: $100.98 million
  • Price / Sales: 1.34
  • Book Value: $1.31 per share
  • Price / Book: 3.53
Profitability:
  • EBIDTA: ($64,730,000.00)
  • Net Margins: -72.75%
  • Return on Equity: -72.84%
  • Return on Assets: -17.99%
Debt:
  • Debt-to-Equity Ratio: 2.87%
  • Current Ratio: 3.87%
  • Quick Ratio: 3.13%
Misc:
  • Average Volume: 188,103 shs.
  • Beta: 3.17
  • Short Ratio: 9.05
 

Frequently Asked Questions for Fluidigm (NASDAQ:FLDM)

What is Fluidigm's stock symbol?

Fluidigm trades on the NASDAQ under the ticker symbol "FLDM."

How were Fluidigm's earnings last quarter?

Fluidigm Co. (NASDAQ:FLDM) posted its quarterly earnings results on Thursday, November, 3rd. The company reported ($0.68) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.67) by $0.01. The business earned $22.20 million during the quarter, compared to the consensus estimate of $27.75 million. Fluidigm had a negative return on equity of 72.84% and a negative net margin of 72.75%. The company's quarterly revenue was down 22.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.15) earnings per share. View Fluidigm's Earnings History.

Where is Fluidigm's stock going? Where will Fluidigm's stock price be in 2017?

3 brokers have issued twelve-month price objectives for Fluidigm's shares. Their forecasts range from $9.00 to $12.00. On average, they anticipate Fluidigm's share price to reach $10.50 in the next twelve months. View Analyst Ratings for Fluidigm.

What are analysts saying about Fluidigm stock?

Here are some recent quotes from research analysts about Fluidigm stock:

  • 1. According to Zacks Investment Research, "Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit (IFC); TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits (IFCs); and Access Array Assay Design Services. The Company's products find its application in Gene Expression, Single-Cell Gene Expression, SNP Genotyping, Targeted Resequencing, Sample Quantitation, Copy Number Variation and Protein Crystallization. Fluidigm Corporation is based in San Francisco, California. " (5/12/2017)
  • 2. Cantor Fitzgerald analysts commented, "XLRS is Progressing. A bright spot in the quarterly earnings release is the XLRS Phase I/II trial, where two patients have already been enrolled in the high dose cohort, and dose expansion data are likely in mid-2017, which is slightly ahead of prior expectations." (2/9/2017)

Are investors shorting Fluidigm?

Fluidigm saw a drop in short interest in the month of April. As of April 13th, there was short interest totalling 1,958,295 shares, a drop of 2.9% from the March 31st total of 2,017,805 shares. Based on an average daily trading volume, of 213,725 shares, the short-interest ratio is presently 9.2 days.

Who are some of Fluidigm's key competitors?

Who owns Fluidigm stock?

Fluidigm's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Levin Capital Strategies L.P. (19.80%), Primecap Management Co. CA (14.69%), Russell Investments Group Ltd. (7.73%), Neuberger Berman Group LLC (6.58%), ADAGE CAPITAL PARTNERS GP, L.L.C. (5.29%) and Vanguard Group Inc. (4.04%). Company insiders that own Fluidigm stock include Gajus Vincent Worthington, Levin Capital Strategies, LP, Samuel D Colella, Stephen Christopher Linthwaite, Vikram Jog and William Maxwell Smith. View Institutional Ownership Trends for Fluidigm.

Who sold Fluidigm stock? Who is selling Fluidigm stock?

Fluidigm's stock was sold by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., TIAA CREF Investment Management LLC, California Public Employees Retirement System, Alliancebernstein L.P., Primecap Management Co. CA and Goldman Sachs Group Inc.. View Insider Buying and Selling for Fluidigm.

Who bought Fluidigm stock? Who is buying Fluidigm stock?

Fluidigm's stock was acquired by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Paloma Partners Management Co, Acadian Asset Management LLC, Bank of New York Mellon Corp, Levin Capital Strategies L.P., Renaissance Technologies LLC, Russell Investments Group Ltd. and Vanguard Group Inc.. Company insiders that have bought Fluidigm stock in the last two years include Levin Capital Strategies, LP, Samuel D Colella and Stephen Christopher Linthwaite. View Insider Buying and Selling for Fluidigm.

How do I buy Fluidigm stock?

Shares of Fluidigm can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Fluidigm stock cost?

One share of Fluidigm stock can currently be purchased for approximately $4.62.

Analyst Ratings

Consensus Ratings for Fluidigm (NASDAQ:FLDM) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.50 (127.27% upside)

Analysts' Ratings History for Fluidigm (NASDAQ:FLDM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/9/2017Cantor FitzgeraldSet Price TargetBuy$9.00N/AView Rating Details
8/5/2016MizuhoBoost Price TargetBuy$11.00 -> $12.00N/AView Rating Details
6/1/2016Deutsche Bank AGInitiated CoverageBuyN/AView Rating Details
4/12/2016Leerink SwannLower Price TargetOutperform$20.00 -> $15.00N/AView Rating Details
1/20/2016Cowen and CompanyReiterated RatingOutperform -> Market PerformN/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$20.00N/AView Rating Details
8/27/2015Maxim GroupReiterated RatingHold$15.00N/AView Rating Details
8/7/2015Piper Jaffray CompaniesDowngradeOverweight -> Neutral$43.00 -> $15.00N/AView Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for Fluidigm (NASDAQ:FLDM)
Earnings by Quarter for Fluidigm (NASDAQ:FLDM)
Earnings History by Quarter for Fluidigm (NASDAQ:FLDM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2017Q4 2016($0.61)($0.61)$25.91 million$25.10 millionViewListenView Earnings Details
11/3/2016Q3($0.67)($0.68)$27.75 million$22.20 millionViewN/AView Earnings Details
8/4/2016Q2($0.58)($0.64)$29.62 million$28.20 millionViewN/AView Earnings Details
5/5/2016Q116($0.53)($0.40)$26.95 million$29.00 millionViewN/AView Earnings Details
10/29/2015Q315($0.55)($0.15)$27.54 million$28.60 millionViewListenView Earnings Details
8/6/2015Q215($0.48)($0.53)$30.43 million$28.62 millionViewListenView Earnings Details
5/7/2015Q115($0.40)($0.39)$30.70 million$26.70 millionViewListenView Earnings Details
2/5/2015Q414($0.43)($0.39)$33.34 million$33.50 millionViewListenView Earnings Details
10/30/2014Q314($0.04)($0.49)$29.20 million$29.60 millionViewN/AView Earnings Details
7/31/2014Q214($0.50)($0.45)$27.13 million$27.60 millionViewN/AView Earnings Details
2/6/2014Q413($0.15)($0.04)$20.73 million$20.90 millionViewN/AView Earnings Details
10/30/2013Q313($0.20)($0.06)$16.70 million$18.30 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.17)($0.07)$15.87 million$17.50 millionViewN/AView Earnings Details
11/7/2012Q312($0.21)($0.12)$13.35 million$12.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Fluidigm (NASDAQ:FLDM)
Current Year EPS Consensus Estimate: $-2.18 EPS
Next Year EPS Consensus Estimate: $-1.53 EPS

Dividends

Dividend History for Fluidigm (NASDAQ:FLDM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Fluidigm (NASDAQ:FLDM)
Insider Ownership Percentage: 4.50%
Insider Trades by Quarter for Fluidigm (NASDAQ:FLDM)
Institutional Ownership by Quarter for Fluidigm (NASDAQ:FLDM)
Insider Trades by Quarter for Fluidigm (NASDAQ:FLDM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2017Samuel D ColellaDirectorBuy7,500$5.93$44,475.00View SEC Filing  
3/14/2017Samuel D ColellaDirectorBuy10,000$5.00$50,000.00View SEC Filing  
12/14/2016Samuel D ColellaDirectorBuy5,000$7.39$36,950.00View SEC Filing  
11/30/2016Samuel D ColellaDirectorBuy20,000$6.32$126,400.00View SEC Filing  
11/30/2016Stephen Christopher LinthwaiteCEOBuy55,000$6.36$349,800.00View SEC Filing  
11/7/2016Levin Capital Strategies, L.P.InsiderBuy159,200$4.44$706,848.00View SEC Filing  
11/2/2016Levin Capital Strategies, L.P.InsiderBuy48,302$4.44$214,460.88View SEC Filing  
10/1/2015Gajus Vincent WorthingtonCEOSell6,000$8.05$48,300.00View SEC Filing  
9/2/2015Gajus Vincent WorthingtonCEOSell12,000$11.53$138,360.00View SEC Filing  
6/16/2015Vikram JogCFOSell3,550$25.00$88,750.00View SEC Filing  
6/15/2015William Maxwell SmithEVPSell3,000$24.20$72,600.00View SEC Filing  
6/1/2015Gajus Vincent WorthingtonCEOSell6,000$23.71$142,260.00View SEC Filing  
4/20/2015Mai Chan YowInsiderSell15,300$44.73$684,369.00View SEC Filing  
4/17/2015Mai Chan YowInsiderSell4,700$44.04$206,988.00View SEC Filing  
4/17/2015William Maxwell SmithEVPSell3,000$43.05$129,150.00View SEC Filing  
4/8/2015Mai Chan YowInsiderSell30,000$42.67$1,280,100.00View SEC Filing  
4/7/2015Vikram JogCFOSell3,950$40.81$161,199.50View SEC Filing  
4/1/2015Gajus Vincent WorthingtonCEOSell6,000$40.02$240,120.00View SEC Filing  
4/1/2015Robert C JonesEVPSell3,000$41.63$124,890.00View SEC Filing  
3/16/2015William Maxwell SmithEVPSell3,000$40.87$122,610.00View SEC Filing  
3/9/2015Vikram JogCFOSell3,950$41.48$163,846.00View SEC Filing  
3/2/2015Evan/ Fa JonesDirectorSell7,500$44.15$331,125.00View SEC Filing  
3/2/2015Gajus Vincent WorthingtonCEOSell6,000$43.77$262,620.00View SEC Filing  
3/2/2015Robert C JonesEVPSell3,000$43.78$131,340.00View SEC Filing  
2/20/2015Samuel D ColellaDirectorSell44,540$38.97$1,735,723.80View SEC Filing  
2/2/2015Gajus Vincent WorthingtonCEOSell6,000$38.15$228,900.00View SEC Filing  
1/15/2015William Maxwell SmithEVPSell3,000$34.24$102,720.00View SEC Filing  
1/2/2015Gajus Vincent WorthingtonCEOSell6,000$33.37$200,220.00View SEC Filing  
12/15/2014William Maxwell SmithEVPSell3,000$27.20$81,600.00View SEC Filing  
12/12/2014Evan/ Fa JonesDirectorSell8,352$27.44$229,178.88View SEC Filing  
12/9/2014Evan/ Fa JonesDirectorSell3,336$28.34$94,542.24View SEC Filing  
12/8/2014Evan/ Fa JonesDirectorSell1,000$29.06$29,060.00View SEC Filing  
12/8/2014Vikram JogCFOSell3,950$29.07$114,826.50View SEC Filing  
12/1/2014Gajus Vincent WorthingtonCEOSell6,000$30.03$180,180.00View SEC Filing  
11/17/2014William Maxwell SmithEVPSell3,000$29.52$88,560.00View SEC Filing  
11/12/2014Evan/ Fa JonesDirectorSell5,000$29.55$147,750.00View SEC Filing  
11/7/2014Vikram JogCFOSell3,950$29.45$116,327.50View SEC Filing  
10/24/2014Mai Chan YowInsiderSell10,000$28.00$280,000.00View SEC Filing  
10/7/2014Vikram JogCFOSell3,950$22.65$89,467.50View SEC Filing  
9/15/2014William Maxwell SmithEVPSell3,000$30.83$92,490.00View SEC Filing  
9/8/2014Vikram JogCFOSell3,950$28.57$112,851.50View SEC Filing  
9/2/2014Gajus Vincent WorthingtonCEOSell6,000$28.16$168,960.00View SEC Filing  
8/7/2014Vikram JogCFOSell3,733$26.34$98,327.22View SEC Filing  
8/6/2014Gajus Vincent WorthingtonCEOSell6,000$26.53$159,180.00View SEC Filing  
7/15/2014William Maxwell SmithEVPSell3,000$31.98$95,940.00View SEC Filing  
7/7/2014Vikram JogCFOSell5,427$30.61$166,120.47View SEC Filing  
7/1/2014Gajus Vincent WorthingtonCEOSell6,000$29.72$178,320.00View SEC Filing  
6/16/2014William Maxwell SmithEVPSell3,000$27.64$82,920.00View SEC Filing  
6/2/2014Gajus Vincent WorthingtonCEOSell6,000$26.55$159,300.00View SEC Filing  
5/15/2014William Maxwell SmithEVPSell3,000$28.53$85,590.00View SEC Filing  
5/8/2014Gajus Vincent WorthingtonCEOSell6,000$32.14$192,840.00View SEC Filing  
4/15/2014William Maxwell SmithEVPSell3,000$35.32$105,960.00View SEC Filing  
4/7/2014Vikram JogCFOSell5,091$37.51$190,963.41View SEC Filing  
3/17/2014William Maxwell SmithEVPSell3,000$47.76$143,280.00View SEC Filing  
11/6/2013Gajus Vincent WorthingtonCEOSell11,832$30.03$355,314.96View SEC Filing  
9/3/2013Gajus Vincent WorthingtonCEOSell10,000$20.53$205,300.00View SEC Filing  
9/3/2013William Maxwell SmithEVPSell7,000$20.42$142,940.00View SEC Filing  
8/30/2013Robert JonesEVPSell3,500$20.36$71,260.00View SEC Filing  
8/14/2013Samuel ColellaDirectorSell23,192$19.91$461,752.72View SEC Filing  
8/8/2013William Maxwell SmithEVPSell16,000$20.02$320,320.00View SEC Filing  
8/6/2013Gajus Vincent WorthingtonCEOSell10,000$19.49$194,900.00View SEC Filing  
8/6/2013Robert JonesEVPSell3,500$19.16$67,060.00View SEC Filing  
7/8/2013Vikram JogCFOSell5,661$17.05$96,520.05View SEC Filing  
7/1/2013Gajus Vincent WorthingtonCEOSell10,000$17.14$171,400.00View SEC Filing  
7/1/2013William Maxwell SmithEVPSell5,000$17.11$85,550.00View SEC Filing  
6/28/2013Robert C JonesEVPSell3,500$17.11$59,885.00View SEC Filing  
6/7/2013Vikram JogCFOSell5,661$16.00$90,576.00View SEC Filing  
6/3/2013Gajus Vincent WorthingtonCEOSell10,000$17.00$170,000.00View SEC Filing  
6/3/2013William Maxwell SmithInsiderSell5,000$16.96$84,800.00View SEC Filing  
5/31/2013Robert C JonesEVPSell3,500$16.93$59,255.00View SEC Filing  
3/4/2013Mai Chan YowInsiderSell30,000$18.15$544,500.00View SEC Filing  
2/4/2013Robert C JonesEVPSell6,984$16.61$116,004.24View SEC Filing  
2/1/2013Gajus Vincent WorthingtonCEOSell10,000$16.60$166,000.00View SEC Filing  
12/28/2012William Maxwell SmithInsiderSell4,504$14.11$63,551.44View SEC Filing  
12/26/2012William Maxwell SmithInsiderSell6,756$14.36$97,016.16View SEC Filing  
12/14/2012Evan/ Fa JonesDirectorBuy10,000$14.36$143,600.00View SEC Filing  
12/11/2012Evan/ Fa JonesDirectorBuy1,971$14.00$27,594.00View SEC Filing  
12/5/2012William Maxwell SmithEVPSell6,756$14.25$96,273.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Fluidigm (NASDAQ:FLDM)
Latest Headlines for Fluidigm (NASDAQ:FLDM)
Source:
DateHeadline
finance.yahoo.com logoETFs with exposure to Fluidigm Corp. : May 15, 2017
finance.yahoo.com - May 15 at 4:51 PM
americanbankingnews.com logoFluidigm Co. (FLDM) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - May 12 at 10:06 PM
finance.yahoo.com logoFluidigm Corp. :FLDM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
finance.yahoo.com - May 12 at 5:45 PM
americanbankingnews.com logoFY2017 EPS Estimates for Fluidigm Co. (FLDM) Cut by Cantor Fitzgerald
www.americanbankingnews.com - May 12 at 12:52 PM
americanbankingnews.com logoSamuel D. Colella Buys 7,500 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - May 11 at 8:26 PM
americanbankingnews.com logoZacks: Analysts Expect Fluidigm Co. (FLDM) Will Announce Earnings of -$0.39 Per Share
www.americanbankingnews.com - May 9 at 12:22 AM
finance.yahoo.com logoFluidigm reports 1Q loss
finance.yahoo.com - May 5 at 5:25 PM
finance.yahoo.com logoEdited Transcript of FLDM earnings conference call or presentation 4-May-17 9:00pm GMT
finance.yahoo.com - May 5 at 5:25 PM
finance.yahoo.com logoInvestor Network: Fluidigm Corporation to Host Earnings Call
finance.yahoo.com - May 4 at 5:19 PM
finance.yahoo.com logoFluidigm Announces First Quarter Financial Results
finance.yahoo.com - May 4 at 5:19 PM
finance.yahoo.com logoEuropean Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research
finance.yahoo.com - May 4 at 5:19 PM
americanbankingnews.com logoSomewhat Favorable News Coverage Very Likely to Affect Fluidigm (FLDM) Stock Price
www.americanbankingnews.com - May 3 at 3:34 PM
americanbankingnews.com logoFluidigm (FLDM) Given Daily News Impact Rating of 0.04
www.americanbankingnews.com - April 29 at 3:53 PM
americanbankingnews.com logoFluidigm Co. (FLDM) Short Interest Update
www.americanbankingnews.com - April 28 at 9:16 PM
finance.yahoo.com logoCerner (CERN) Earnings and Revenues Beat Estimates in Q1
finance.yahoo.com - April 28 at 8:32 AM
americanbankingnews.com logoFluidigm (FLDM) Receives Media Impact Score of 0.10
www.americanbankingnews.com - April 26 at 11:52 PM
americanbankingnews.com logoFavorable Press Coverage Very Likely to Impact Fluidigm (FLDM) Stock Price
www.americanbankingnews.com - April 21 at 8:21 PM
finance.yahoo.com logoFluidigm to Report Q1 2017 Financial Results and Host Conference Call
finance.yahoo.com - April 20 at 5:19 PM
americanbankingnews.com logoFluidigm (FLDM) Earns Media Impact Rating of 0.43
www.americanbankingnews.com - April 15 at 10:07 AM
americanbankingnews.com logoFluidigm Co. (FLDM) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - April 10 at 7:40 PM
finance.yahoo.com logoBecton, Dickinson Takes Over Caesarea Medical Electronics
finance.yahoo.com - April 7 at 9:48 AM
finance.yahoo.com logoTeleflex (TFX) Acquires Medical Device Provider Pyng Medical
finance.yahoo.com - April 7 at 9:48 AM
finance.yahoo.com logoMazor Expects Higher Q1 Revenue, Receives Mazor X Orders
finance.yahoo.com - April 7 at 9:48 AM
finance.yahoo.com logoPAREXEL (PRXL) Launches Sensor for Clinical Trial Market
finance.yahoo.com - March 31 at 5:19 PM
finance.yahoo.com logoZacks.com featured highlights: United Bankshares, TopBuild, WSFS Financial, Fluidigm and Otter Tail
finance.yahoo.com - March 29 at 11:22 AM
us.rd.yahoo.com logoNicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors
us.rd.yahoo.com - March 27 at 4:56 PM
finance.yahoo.com logoCogentix (CGNT) Q4 Earnings and Revenues Miss Estimates
finance.yahoo.com - March 10 at 11:19 AM
finance.yahoo.com logoFLUIDIGM CORP Financials
finance.yahoo.com - March 8 at 6:01 PM
finance.yahoo.com logoTransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4
finance.yahoo.com - March 7 at 11:34 AM
biz.yahoo.com logoFLUIDIGM CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 3 at 5:15 PM
biz.yahoo.com logoFLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 2 at 5:29 PM
finance.yahoo.com logoFluidigm to Present at Cowen and Company 37th Annual Health Care Conference
finance.yahoo.com - February 23 at 5:13 PM
finance.yahoo.com logoDaVita (DVA) Ties Up with Cigna Arm, Expands in Los Angeles
finance.yahoo.com - February 22 at 10:19 AM
finance.yahoo.com logoWright Medical (WMGI) Posts Narrower-than-Expected Q4 Loss
finance.yahoo.com - February 22 at 10:19 AM
finance.yahoo.com logoDENTSPLY (XRAY) Beats on Earnings in Q4, Misses Revenues
finance.yahoo.com - February 17 at 3:47 PM
finance.yahoo.com logoEdited Transcript of FLDM earnings conference call or presentation 8-Feb-17 10:00pm GMT
finance.yahoo.com - February 9 at 5:51 PM
us.rd.yahoo.com logo4:04 pm Fluidigm misses by $0.09, reports revs in-line; guides Q1 revs below consensus
us.rd.yahoo.com - February 8 at 10:44 PM
biz.yahoo.com logoQ4 2016 Fluidigm Corp Earnings Release - After Market Close
us.rd.yahoo.com - February 8 at 5:43 PM
us.rd.yahoo.com logoFluidigm Announces Q4 and Full Year 2016 Financial Results
us.rd.yahoo.com - February 8 at 5:43 PM
biz.yahoo.com logoFLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
us.rd.yahoo.com - February 8 at 5:43 PM
feeds.benzinga.com logoFluidigm to Report Q4 and Full Year 2016 Financial Results and Host Conference Call
feeds.benzinga.com - January 25 at 4:49 PM
finance.yahoo.com logoFluidigm: Q4 Preliminary Results Fail to Cheer Investors
finance.yahoo.com - January 12 at 4:07 PM

Social

Chart

Fluidigm (FLDM) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff